Journal of Inherited Metabolic Disease

, Volume 29, Issue 6, pp 705–706 | Cite as

Commentary on: The aetiology of neurological complications of organic acidaemias—a role for the blood–brain barrier. Kölker S, Sauer SW, Surtees RAH, Leonard JV

  • A. A. M. Morris


Methylmalonic Glutaric Aciduria Type Acute Encephalopathy Methylmalonate Methylmalonic Acidemia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Chakrapani A, Sivakumar P, McKiernan PJ, Leonard JV (2002) Metabolic stroke in methylmalonic acidemia five years after liver transplantation. J Pediatr 140: 261–263.PubMedCrossRefGoogle Scholar
  2. Funk CB, Prasad AN, Frosk P, et al (2005) Neuropathological, biochemical and molecular findings in a glutaric acidemia type 1 cohort. Brain 128: 711–722.PubMedCrossRefGoogle Scholar
  3. Hassel B, Brathe A, Petersen D (2002) Cerebral dicarboxylate transport and metabolism studied with isotopically labelled fumarate, malate and malonate. J Neurochem 82: 410–419.PubMedCrossRefGoogle Scholar
  4. Hoffmann GF, Meier-Augenstein W, Stockler S, Surtees R, Rating D, Nyhan WL (1993) Physiology and pathophysiology of organic acids in cerebrospinal fluid. J Inherit Metab Dis 16: 648–669.PubMedCrossRefGoogle Scholar
  5. Kölker S, Ahlemeyer B, Huhne R, Mayatepek E, Krieglstein J, Hoffmann GF (2001) Potentiation of 3-hydroxyglutarate neurotoxicity following induction of astrocytic iNOS in neonatal rat hippocampal cultures. Eur J Neurosci 13: 2115–2122.PubMedCrossRefGoogle Scholar
  6. Kölker S, Schwab M, Horster F, et al (2003) Methylmalonic acid, a biochemical hallmark of methylmalonic acidurias but no inhibitor of mitochondrial respiratory chain. J Biol Chem 278: 47388–47393.PubMedCrossRefGoogle Scholar
  7. Kölker S, Sauer SW, Surtees RAH, Leonard JV (2006) The aetiology of neurological complications of organic acidaemias – a role for the blood–brain barrier. J Inherit Metab Dis 29: 701–704.Google Scholar
  8. Kulkens S, Harting I, Sauer S, et al (2005) Late-onset neurologic disease in glutaryl-CoA dehydrogenase deficiency. Neurology 64: 2142–2144.PubMedCrossRefGoogle Scholar
  9. Oldendorf WH (1973) Carrier-mediated blood–brain barrier transport of short-chain monocarboxylic organic acids. Am J Physiol 224: 1450–1453.PubMedGoogle Scholar
  10. Sauer SW, Okun JG, Fricker G, et al (2006) Intracerebral accumulation of glutaric and 3-hydroxyglutaric acids secondary to limited flux across the blood–brain barrier constitute a biochemical risk factor for neurodegeneration in glutaryl-CoA dehydrogenase deficiency. J Neurochem 97: 899–910.PubMedCrossRefGoogle Scholar
  11. Schwab MA, Sauer SW, Okun JG, et al (2006) Secondary mitochondrial dysfunction in propionic aciduria: a pathogenic role for endogenous mitochondrial toxins. Biochem J 398: 107–112.PubMedCrossRefGoogle Scholar
  12. Varadkar S, Surtees R (2004) Glutaric aciduria type I and kynurenine pathway metabolites: a modified hypothesis. J Inherit Metab Dis 27: 835–842.PubMedCrossRefGoogle Scholar

Copyright information

© SSIEM and Springer 2006

Authors and Affiliations

  1. 1.Willink Biochemical Genetics UnitRoyal Manchester Children’s HospitalManchesterUK

Personalised recommendations